Your request to subscribe to our newsletter has been received.
How we help you
Latest News / Events
Bladder Cancer: SMC Approve use of Avelumab (Bavencio) for use in Scotland 09/08/2021
Bladder Cancer: SMC Approve use of Avelumab (Bavencio) for
use in Scotland
Action Bladder Cancer UK are delighted that the Scottish
Medicines Consortium have announced today that the immunotherapy Avelumab
(Bavencio) has been accepted for use in Scotland.
In a phase III study, ma...